13F filer · CIK 1631614
New Leaf Venture Partners, L.L.C.
New York, NY · filing since Q4 2014 · last filing Nov 14, 2025
Reported value
$43.0M
$-9.9M vs prior
Positions
7
New / sold out
0 / 1
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $19.7M
Top-10 weight
100.0%
Biggest buys vs Q2 2025
No new or increased positions this quarter.
Biggest sells vs Q2 2025
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | PASG | -2,410,496 | -96.5% | $-19.4M |
| Sold out | ITERUM THERAPEUTICS PLC | -345,020 | -100.0% | $-343.3K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2025
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | EWTXEDGEWISE THERAPEUTICS INC | 1,030,161 | $16.7M | 38.82% |
| 2 | ARVNARVINAS INC | 1,585,721 | $13.5M | 31.38% |
| 3 | CRNXCRINETICS PHARMACEUTICALS INC | 141,000 | $5.9M | 13.64% |
| 4 | COGTCOGENT BIOSCIENCES INC. | 250,765 | $3.6M | 8.37% |
| 5 | RLYBRALLYBIO CORPORATION | 3,301,603 | $1.6M | 3.83% |
| 6 | ALECALECTOR INC | 339,569 | $1.0M | 2.33% |
| 7 | PASGPASSAGE BIO | 87,426 | $702.0K | 1.63% |